Krypton red laser photocoagulation of the ocular fundus.
The theoretical rationale, the histopathologic evidence, and the preliminary clinical studies related to krypton red laser (KRL) photocoagulation of the ocular fundus are reviewed. The authors report on their experience with currently available laser systems using this wavelength (647.1 nm) for photocoagulation of retinal vascular proliferative diseases and chorioretinal diseases associated with exudative manifestations. A histopathologic and clinical comparison of argon blue-green laser (ABGL), the pure argon green laser (AGL), and the krypton yellow laser (KYL), with reference to photocoagulation treatment of the ocular fundus is also discussed.
D003930:Diabetic Retinopathy / Q000601:surgery; D005451:Fluorescein Angiography; D005584:Fovea Centralis / Q000098:blood supply; D006801:Humans; D053685:Laser Therapy; D007834:Lasers / Q000379:methods*; D008266:Macula Lutea / Q000098:blood supply; D008268:Macular Degeneration / Q000601:surgery; D009389:Neovascularization, Pathologic; D011183:Postoperative Complications / Q000209:etiology; D012162:Retinal Degeneration / Q000601:surgery; D012164:Retinal Diseases / Q000601:surgery*; D012166:Retinal Hemorrhage / Q000209:etiology; D012171:Retinal Vessels / Q000473:pathology